Khurram Jamil Insider Trades & Stock Holdings

Chief Medical Officer · Galectin Therapeutics Inc. · Latest filing Jun 29, 2026

Khurram Jamil, Chief Medical Officer at Galectin Therapeutics Inc. has 7 Form 4 trades on file since Jun 23, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($262.96K), net -$262.96K. Latest filing: disposed of 47.47K shares of $GALT on Jun 29, 2026 at $5.04.

Trades on file

7

Open-market bought

$0

Open-market sold

$262.96K

Net open-market

-$262.96K

Latest filing

Jun 29, 2026

All insider trades by Khurram Jamil

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 29, 2026	$GALT	Sell (Open-market sale) 10b5-1	47.47K	$5.04	$239.23K			-6.8%	-29.8%		Chief Medical Officer		Read
Jun 29, 2026	$GALT	Buy (Option exercise)	47.47K	$2.50	$118.67K			-6.8%	-29.8%		Chief Medical Officer		—
Jun 26, 2026	$GALT	Sell (Option exercise)	2.53K	$0	—			-7.2%	-32.3%		Chief Medical Officer		Read
Jun 26, 2026	$GALT	Buy (Option exercise)	4.57K	$2.37	$10.81K			-7.2%	-32.3%		Chief Medical Officer		Read
Jun 23, 2026	$GALT	Sell (Open-market sale) 10b5-1	7.56K	$3.14	$23.73K			+48.7%	+10.6%		Chief Medical Officer		—
Jun 23, 2026	$GALT	Sell (Option exercise)	7.56K	$0	—			+48.7%	+10.6%		Chief Medical Officer		—
Jun 23, 2026	$GALT	Buy (Option exercise)	7.56K	$1.23	$9.30K			+48.7%	+10.6%		Chief Medical Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Khurram Jamil traded

• $GALT

Frequently asked questions

Has Khurram Jamil been buying or selling stock?

Khurram Jamil has 0 open-market purchases and 2 open-market sales on file, net -$262.96K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Khurram Jamil's latest insider trade?

disposed of 47.47K shares of $GALT on Jun 29, 2026 at $5.04.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.